S

Sofinnova Partners

79 employees

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

Investor insights

Countries invested in

canada1
united states3

Sectors invested in

Biotechnology160
Health Care104
Medical59
Therapeutics52
Pharmaceutical46
Medical Device40
Life Science28
Software24
Manufacturing23
Biopharma22
Clinical Trials19
oncology17
Chemical14
Mobile10
Hardware10
biotechnology10
Agriculture9
Electronics8
Food and Beverage7
Genetics7

Funding rounds participated in

$17M sweet spot round size

Most of their 273 investments are in rounds between $8.4M and $36M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Biotechnology
Medical devices
Financial Services
Biotech
Finance
Pharmaceutical / biotech
Impact Investing
Medtech
Private Equity
Sustainability
Industrial Biotechnology
Asset Management
Biopharma
Venture Capital

Date founded

1972

Investments made

M

Mironid® Limited raised $38M on September 13, 2023

Investors: BGV (BioGeneration Ventures), Scottish Enterprise, Epidarex Capital, University of Strathclyde and Sofinnova Partners

G

Gradient Denervation Technologies raised $15M on September 7, 2023

Investors: Thuja Capital, Asabys Partners and Sofinnova Partners

S

Sensorion raised $38M on August 3, 2023

Investors: Redmile Group, The Invus Group and Sofinnova Partners

G

GenSight Biologics raised $6.6M on August 3, 2023

Investors: The Invus Group, UPMC Enterprises and Sofinnova Partners

C

Crescendo Biologics Limited raised $32M on July 24, 2023

Investors: Quan Capital 泉创资本, Andera Partners, Kreos Capital, - and Sofinnova Partners

B

BrightHeart raised $2.1M on May 31, 2023

Investors: Sofinnova Partners

T

TISSIUM raised $54M on May 23, 2023

Investors: FSI - Fonds Stratégique d'Investissement, Cathay Health, Crédit Mutuel Innovation and Sofinnova Partners

M

Moon Surgical raised $55M on May 17, 2023

Investors: MD Start and Sofinnova Partners

W

Werewool raised $3.7M on May 10, 2023

Investors: Material Impact and Sofinnova Partners

A

Alia Therapeutics raised $4.8M on April 17, 2023

Investors: BiovelocITA, Indaco Venture Partners and Sofinnova Partners

FAQ